Protagonist Therapeutics, Inc. (PTGX)

Protagonist Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,371	2,300	1,323	537	1,632	867
Market Cap Growth	76.08%	73.94%	146.40%	-67.12%	88.22%	352.15%
Enterprise Value	2,684	1,728	1,002	274	1,286	674
Last Close Price	54.38	38.60	22.93	10.91	34.20	20.16
PE Ratio	63.05	8.36	-	-	-	-
PS Ratio	16.25	5.30	22.04	20.19	59.67	30.29
PB Ratio	4.89	3.41	3.93	2.49	5.44	3.10
P/TBV Ratio	4.89	3.41	3.93	2.49	5.44	3.10
P/FCF Ratio	10.05	12.59	-	-	-	-
P/OCF Ratio	10.00	12.49	-	-	-	-
EV/Sales Ratio	12.92	3.98	16.69	10.29	47.01	23.53
EV/EBITDA Ratio	95.68	6.81	-	-	-	-
EV/EBIT Ratio	98.59	6.84	-	-	-	-
EV/FCF Ratio	8.01	9.45	-	-	-	-
Debt / Equity Ratio	0.02	0.02	0.00	0.02	0.02	0.02
Debt / EBITDA Ratio	0.37	0.04	-	-	-	-
Debt / FCF Ratio	0.03	0.06	-	-	-	-
Asset Turnover	0.30	0.79	0.20	0.09	0.08	0.12
Quick Ratio	17.13	12.39	16.54	7.61	7.55	7.69
Current Ratio	17.26	12.48	16.71	7.80	7.74	7.84
Return on Equity (ROE)	9.00%	54.39%	-28.59%	-49.41%	-43.32%	-36.79%
Return on Assets (ROA)	2.48%	28.66%	-19.32%	-27.57%	-23.40%	-16.82%
Return on Capital (ROIC)	2.70%	30.86%	-21.01%	-31.27%	-26.60%	-21.08%
Return on Capital Employed (ROCE)	3.90%	36.30%	-	-	-	-
Earnings Yield	1.67%	11.96%	-5.97%	-23.73%	-7.69%	-7.63%
FCF Yield	9.95%	7.95%	-5.36%	-20.29%	-6.68%	-8.41%
Buyback Yield / Dilution	-8.17%	-14.65%	-15.74%	-5.87%	-34.67%	-32.84%

Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q